WILLIAM PEACOCK to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications WILLIAM PEACOCK has written about Randomized Controlled Trials as Topic.
Connection Strength
0.355
-
Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): design of a multicentre, randomised, double-blind, placebo-controlled, parallel-group study. BMJ Open. 2023 06 12; 13(6):e071311.
Score: 0.149
-
Initial results from the PROACTION study. J Emerg Med. 2006 Nov; 31(4):435-6.
Score: 0.047
-
Safety of treating acute pulmonary embolism at home: an individual patient data meta-analysis. Eur Heart J. 2024 Aug 21; 45(32):2933-2950.
Score: 0.040
-
Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies. Curr Med Res Opin. 2017 09; 33(9):1697-1703.
Score: 0.025
-
Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future. Pharmacol Res. 2016 11; 113(Pt A):585-591.
Score: 0.023
-
Doses of apixaban and rivaroxaban prescribed in real-world United States cardiology practices compared to registration trials. Curr Med Res Opin. 2016 07; 32(7):1277-9.
Score: 0.023
-
Early management of patients with acute heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/heart failure society of America acute heart failure working group. J Card Fail. 2015 Jan; 21(1):27-43.
Score: 0.020
-
Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. JACC Cardiovasc Imaging. 2009 Jul; 2(7):897-907.
Score: 0.014
-
Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. Circ Cardiovasc Imaging. 2009 Jul; 2(4):339-48.
Score: 0.014